IL103874A0 - Compounds for binding therapeutically effective substances to lipid containing particles and pharmaceutical compositions containing the same - Google Patents
Compounds for binding therapeutically effective substances to lipid containing particles and pharmaceutical compositions containing the sameInfo
- Publication number
- IL103874A0 IL103874A0 IL103874A IL10387492A IL103874A0 IL 103874 A0 IL103874 A0 IL 103874A0 IL 103874 A IL103874 A IL 103874A IL 10387492 A IL10387492 A IL 10387492A IL 103874 A0 IL103874 A0 IL 103874A0
- Authority
- IL
- Israel
- Prior art keywords
- compounds
- pharmaceutical compositions
- therapeutically effective
- same
- effective substances
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0453—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1258—Pills, tablets, lozenges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Optics & Photonics (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Polymers & Plastics (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US79893691A | 1991-11-27 | 1991-11-27 | |
US07/884,432 US5667764A (en) | 1988-05-02 | 1992-05-15 | Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles |
Publications (1)
Publication Number | Publication Date |
---|---|
IL103874A0 true IL103874A0 (en) | 1993-04-04 |
Family
ID=27122052
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL103874A IL103874A0 (en) | 1991-11-27 | 1992-11-25 | Compounds for binding therapeutically effective substances to lipid containing particles and pharmaceutical compositions containing the same |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0643706A1 (en) |
JP (2) | JP3682974B2 (en) |
CN (1) | CN1074911A (en) |
AU (2) | AU3221993A (en) |
CA (1) | CA2124329C (en) |
IL (1) | IL103874A0 (en) |
MX (1) | MX9206844A (en) |
NZ (1) | NZ245271A (en) |
PH (1) | PH31676A (en) |
WO (1) | WO1993011120A1 (en) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE339975T1 (en) † | 1993-07-19 | 2006-10-15 | Angiotech Pharm Inc | ANTI-ANGIOGENIC STENT AND METHOD FOR THE PRODUCTION THEREOF |
ES2210258T5 (en) | 1993-07-29 | 2009-01-16 | The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services | PROCEDURE OF TREATMENT OF ATEROSCLEROSIS OR RESTENOSIS USING A STABILIZING AGENT OF MICROTUBLES. |
US5480901A (en) * | 1994-10-07 | 1996-01-02 | Zynaxis, Inc. | Method for reducing unwanted cellular adhesions |
US6492332B1 (en) | 1995-12-12 | 2002-12-10 | Omeros Corporation | Irrigation solution and methods for inhibition of tumor cell adhesion, pain and inflammation |
US6004536A (en) * | 1995-11-14 | 1999-12-21 | Molecular Probes, Inc. | Lipophilic cyanine dyes with enchanced aqueous solubilty |
WO1997024459A1 (en) * | 1995-12-29 | 1997-07-10 | Phanos Technologoes, Inc. | Method for reducing unwanted cellular adhesions |
US5871436A (en) * | 1996-07-19 | 1999-02-16 | Advanced Cardiovascular Systems, Inc. | Radiation therapy method and device |
US6495579B1 (en) | 1996-12-02 | 2002-12-17 | Angiotech Pharmaceuticals, Inc. | Method for treating multiple sclerosis |
US6515016B2 (en) | 1996-12-02 | 2003-02-04 | Angiotech Pharmaceuticals, Inc. | Composition and methods of paclitaxel for treating psoriasis |
WO1998043618A2 (en) * | 1997-03-31 | 1998-10-08 | Neorx Corporation | Use of cytoskeletal inhibitors for the prevention of restenosis |
US7208010B2 (en) | 2000-10-16 | 2007-04-24 | Conor Medsystems, Inc. | Expandable medical device for delivery of beneficial agent |
US20040254635A1 (en) | 1998-03-30 | 2004-12-16 | Shanley John F. | Expandable medical device for delivery of beneficial agent |
US6241762B1 (en) | 1998-03-30 | 2001-06-05 | Conor Medsystems, Inc. | Expandable medical device with ductile hinges |
US7045305B1 (en) * | 1998-04-08 | 2006-05-16 | The Regents Of The University Of California | Methods and reagents for targeting organic compounds to selected cellular locations |
US6120847A (en) * | 1999-01-08 | 2000-09-19 | Scimed Life Systems, Inc. | Surface treatment method for stent coating |
US6333347B1 (en) | 1999-01-29 | 2001-12-25 | Angiotech Pharmaceuticals & Advanced Research Tech | Intrapericardial delivery of anti-microtubule agents |
US6419692B1 (en) | 1999-02-03 | 2002-07-16 | Scimed Life Systems, Inc. | Surface protection method for stents and balloon catheters for drug delivery |
US6156373A (en) | 1999-05-03 | 2000-12-05 | Scimed Life Systems, Inc. | Medical device coating methods and devices |
NZ517188A (en) * | 1999-08-23 | 2003-11-28 | Angiogene Inc | Radioactively coated device and method of making same for preventing restenosis |
CO5261573A1 (en) | 1999-11-19 | 2003-03-31 | Novartis Ag | DERIVATIVES OF BENZOXA AND BEZOTIAZOL, COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING THEM AND PROCESS FOR THE PREPARATION OF THE MENTIONED COMPOSITION |
IT1319168B1 (en) * | 2000-03-17 | 2003-09-26 | Indena Spa | ANTI-CANCER CONDENSATION DERIVATIVES, THEIR METHOD OF PREPARATION AND FORMULATIONS CONTAINING THEM. |
IL155107A0 (en) | 2000-10-16 | 2003-10-31 | Conor Medsystems Inc | Expandable medical device for delivery of beneficial agent |
DE10115740A1 (en) | 2001-03-26 | 2002-10-02 | Ulrich Speck | Preparation for restenosis prophylaxis |
DE10244847A1 (en) | 2002-09-20 | 2004-04-01 | Ulrich Prof. Dr. Speck | Medical device for drug delivery |
US7776529B2 (en) | 2003-12-05 | 2010-08-17 | Life Technologies Corporation | Methine-substituted cyanine dye compounds |
KR20070091609A (en) | 2004-11-22 | 2007-09-11 | 지이 헬스케어 에이에스 | Contrast Agents for Targeting Extracellular Matrix |
US9050393B2 (en) | 2005-02-08 | 2015-06-09 | Bruce N. Saffran | Medical devices and methods for modulation of physiology using device-based surface chemistry |
EP1885718B1 (en) | 2005-05-11 | 2017-03-15 | Life Technologies Corporation | Fluorescent chemical compounds having high selectivity for double stranded dna, and methods for their use |
US8114429B2 (en) | 2008-09-15 | 2012-02-14 | Cv Ingenuity Corp. | Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens |
US8257722B2 (en) | 2008-09-15 | 2012-09-04 | Cv Ingenuity Corp. | Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens |
US9198968B2 (en) | 2008-09-15 | 2015-12-01 | The Spectranetics Corporation | Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens |
US9956385B2 (en) | 2012-06-28 | 2018-05-01 | The Spectranetics Corporation | Post-processing of a medical device to control morphology and mechanical properties |
TWI637992B (en) * | 2013-11-26 | 2018-10-11 | 住友化學股份有限公司 | Rubber composition and vulcanization aid |
US10525171B2 (en) | 2014-01-24 | 2020-01-07 | The Spectranetics Corporation | Coatings for medical devices |
EP3101012A1 (en) | 2015-06-04 | 2016-12-07 | Bayer Pharma Aktiengesellschaft | New gadolinium chelate compounds for use in magnetic resonance imaging |
US10975060B2 (en) | 2016-11-28 | 2021-04-13 | Bayer Pharma Aktiengesellschaft | High relaxivity gadolinium chelate compounds for use in magnetic resonance imaging |
EP3883613A1 (en) | 2018-11-23 | 2021-09-29 | Bayer Aktiengesellschaft | Formulation of contrast media and process of preparation thereof |
JP7423888B2 (en) * | 2019-11-22 | 2024-01-30 | 株式会社同仁化学研究所 | Dye for staining lipid bilayer membranes and method for staining lipid bilayer membranes using the same |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1523965A (en) * | 1976-03-19 | 1978-09-06 | Ici Ltd | Pharmaceutical compositions containing steroids |
DE3170134D1 (en) * | 1980-09-02 | 1985-05-30 | Fuji Photo Film Co Ltd | Method for immunochemical measurement |
US4501728A (en) * | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
US4751219A (en) * | 1985-02-05 | 1988-06-14 | Nederlandse Centrale Organisatie Voor Toegepast-Natuur-Wetenschappelijk Onderzoek | Synthetic glycolipides, a process for the preparation thereof and several uses for these synthetic glycolipides |
US4762701A (en) * | 1986-10-31 | 1988-08-09 | Smithkline Beckman Corporation | In vivo cellular tracking |
US4783401A (en) * | 1986-10-31 | 1988-11-08 | Smithkline Beckman Corporation | Viable cell labelling |
US4906749A (en) * | 1987-06-30 | 1990-03-06 | Viomedics Inc. | Cyclic anhydride derivatives of chromophors |
EP0396626A1 (en) * | 1988-01-19 | 1990-11-14 | Board Of Regents, The University Of Texas System | Glycosides, liposomal compositions thereof, and methods for their use |
JP3038339B2 (en) * | 1988-05-02 | 2000-05-08 | ザイナクシス・テクノロジーズ・インコーポレーテッド | Compounds that bind bioaffecting substances to the surface membrane of bioparticles |
US5149794A (en) * | 1990-11-01 | 1992-09-22 | State Of Oregon | Covalent lipid-drug conjugates for drug targeting |
-
1992
- 1992-11-24 JP JP51019093A patent/JP3682974B2/en not_active Expired - Lifetime
- 1992-11-24 AU AU32219/93A patent/AU3221993A/en not_active Abandoned
- 1992-11-24 CA CA002124329A patent/CA2124329C/en not_active Expired - Lifetime
- 1992-11-24 EP EP93900600A patent/EP0643706A1/en not_active Withdrawn
- 1992-11-24 WO PCT/US1992/010076 patent/WO1993011120A1/en not_active Application Discontinuation
- 1992-11-25 IL IL103874A patent/IL103874A0/en unknown
- 1992-11-25 NZ NZ245271A patent/NZ245271A/en unknown
- 1992-11-26 CN CN92115176A patent/CN1074911A/en active Pending
- 1992-11-26 PH PH45327A patent/PH31676A/en unknown
- 1992-11-27 MX MX9206844A patent/MX9206844A/en unknown
-
1997
- 1997-04-30 AU AU19914/97A patent/AU1991497A/en not_active Abandoned
-
2002
- 2002-07-01 JP JP2002192417A patent/JP4095847B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2124329A1 (en) | 1993-06-10 |
JPH08502719A (en) | 1996-03-26 |
JP4095847B2 (en) | 2008-06-04 |
WO1993011120A1 (en) | 1993-06-10 |
AU1991497A (en) | 1997-07-10 |
CN1074911A (en) | 1993-08-04 |
CA2124329C (en) | 2008-11-18 |
JP3682974B2 (en) | 2005-08-17 |
EP0643706A4 (en) | 1994-12-27 |
AU3221993A (en) | 1993-06-28 |
JP2003026657A (en) | 2003-01-29 |
MX9206844A (en) | 1993-07-01 |
PH31676A (en) | 1999-01-18 |
NZ245271A (en) | 1996-03-26 |
EP0643706A1 (en) | 1995-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL103874A0 (en) | Compounds for binding therapeutically effective substances to lipid containing particles and pharmaceutical compositions containing the same | |
IL105220A0 (en) | Cyclohexanylidene compounds and pharmaceutical compositions containing them | |
NZ244766A (en) | Bi-aromatic compounds and pharmaceutical compositions | |
IL90067A0 (en) | 1alpha-hydroxyvitamin-d compounds and pharmaceutical compositions containing them | |
IL117237A (en) | Pharmaceutical compositions of piperidinoalkanol compounds in solid unit dosage form | |
IL110376A0 (en) | Pharmaceutical compositions containing ifetroban and methods for the preparation thereof | |
GB9319500D0 (en) | Pharmaceutical composition | |
IL105222A0 (en) | Cyclohex-1-ene compounds and pharmaceutical compositions containing them | |
AU5100393A (en) | Diindolo compounds and pharmaceutical compositions containing them | |
IL108073A0 (en) | Substituted 6-azaandrostenones their preparation and pharmaceutical compositions containing them | |
GB2272375B (en) | Pharmaceutical composition | |
EP0587047A3 (en) | Gestagenes containing pharmaceutical composition | |
SG43083A1 (en) | Benzinidaziles pharmaceutical compositions containing these compounds and processes for preparing them | |
IL109237A0 (en) | Polycyclic compounds and pharmaceutical compositions containing them | |
PL301513A1 (en) | Controllably released pharmaceutical composition containing nitroglycerin | |
IL107611A0 (en) | Steroid compounds and pharmaceutical compositions containing them | |
IL104418A0 (en) | Disubstituted polycyclic compounds and pharmaceutical compositions containing them | |
IL89155A0 (en) | Ouabain-like compounds and pharmaceutical compositions containing them | |
GB9221707D0 (en) | Pharmaceutical composition | |
ZA94155B (en) | Pharmaceutical composition | |
ZA935078B (en) | Pharmaceutical composition | |
IL87444A0 (en) | Pharmaceutical compositions containing polyaromatic compounds | |
IL91350A0 (en) | Phenylalkylthiophenes and related compounds and pharmaceutical compositions containing them | |
IL115853A (en) | Aryloxycycloalkenyl and aryloxyiminocyclo-alkenylhydroxyureas and pharmaceutical compositions containing these compounds | |
ZA935931B (en) | Pharmaceutical composition |